Core Viewpoint - PagerDuty (PD) has experienced a significant downtrend, with a 26.6% decline in stock price over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround due to improved earnings expectations from analysts [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is a key technical indicator used to determine if a stock is oversold, with a reading below 30 typically indicating this condition [2]. - PD's current RSI reading is 25.34, indicating that the heavy selling pressure may be exhausting, which could lead to a price rebound as the stock seeks to return to its previous equilibrium [5]. Group 2: Fundamental Analysis - There is strong consensus among sell-side analysts regarding an increase in earnings estimates for PD, with a 71.7% rise in the consensus EPS estimate over the last 30 days, suggesting potential price appreciation in the near term [7]. - PD holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further indicating a strong potential for a turnaround [8].

Group 1: Market Overview - As of December 2, 2025, two stocks in the health care sector are signaling potential warnings for momentum-focused investors [1] - The Relative Strength Index (RSI) is a key momentum indicator, with values above 70 indicating that a stock may be overbought [2] Group 2: Company Highlights - Exact Sciences Corp (NASDAQ:EXAS) is involved in a significant acquisition by Abbott Laboratories for $105 per share, totaling approximately $21 billion in equity value [7] - Exact Sciences' stock has increased by around 51% over the past month, with a 52-week high of $101.87 and an RSI value of 89.8 [7] - Haemonetics Corp (NYSE:HAE) reported strong second-quarter earnings, with earnings per share of $1.27, surpassing the consensus estimate of $1.11 [7] - Haemonetics' quarterly sales reached $327.316 million, exceeding the analyst consensus estimate of $311.399 million, and the stock has gained approximately 61% over the past month [7] - Haemonetics has a 52-week high of $88.31 and an RSI value of 89.4 [7]

A downtrend has been apparent in H&R Block (HRB) lately with too much selling pressure. The stock has declined 15.3% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. Thi ...

Core Viewpoint - Zscaler (ZS) has experienced a significant decline of 24.1% over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround as analysts expect better earnings than previously predicted [1]. Group 1: Technical Analysis - The Relative Strength Index (RSI) is a key technical indicator used to identify oversold conditions, with a reading below 30 typically indicating that a stock is oversold [2]. - ZS has an RSI reading of 27.83, indicating that the heavy selling pressure may be exhausting, which could lead to a price rebound [5]. - Stocks oscillate between overbought and oversold conditions, and the RSI helps investors identify potential entry points for a rebound [3]. Group 2: Fundamental Analysis - There is strong consensus among sell-side analysts regarding ZS, with earnings estimates for the current year increasing by 11.8% over the last 30 days [7]. - An upward trend in earnings estimate revisions is generally associated with price appreciation in the near term, indicating a positive outlook for ZS [7]. - ZS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate trends and EPS surprises, further supporting the potential for a turnaround [8].

Core Viewpoint - Pi Coin has experienced a 7% drop in the last 24 hours, but its monthly performance remains relatively strong with an 8.7% increase, outperforming Bitcoin and Ethereum [1] Market Performance - The recent decline in Pi Coin's price is part of a broader market pullback, with Bitcoin and Ethereum seeing losses of approximately 21% and 26% respectively over the same period [1] - The price drop was initiated by a bearish crossover on the 12-hour chart, where the 20-period exponential moving average (EMA) fell below the 100-period EMA, indicating short-term downward momentum [1][2] Internal Metrics - The Relative Strength Index (RSI) shows a hidden bullish divergence, indicating potential for upward movement despite the recent price drop [3] - The Chaikin Money Flow (CMF) has increased significantly, suggesting that large investors may be gaining control, which historically correlates with price increases [5] Price Levels and Rebound Potential - For a rebound to be confirmed, Pi Coin needs to close above $0.238, representing a 4% increase from the current price of approximately $0.229 [7] - A successful close above $0.238 could lead to resistance levels at $0.255 and $0.266, with a potential retest of $0.284 if the broader market improves [8] - On the downside, maintaining support around $0.225 and $0.223 is crucial; losing these levels would negate the bullish divergence and shift focus to a demand area near $0.209 [8]

Core Insights - The current market sentiment is shifting towards bearish, indicating a change in short-term trends, which traders need to understand [2][4]. Group 1: Market Trends - Corrections in the market are viewed as healthy opportunities for investors to buy assets at lower prices, despite the panic-driven headlines that can disrupt long-term uptrends [3]. - The short-term trend has turned bearish, as indicated by the 8, 21, and 34 exponential moving averages (EMAs) [4]. Group 2: Technical Indicators - The Relative Strength Index (RSI) has dropped below 50 and is showing a deeper dip beneath 40, suggesting a potential end to the prior uptrend [5][9]. - Multiple bearish EMA crossovers and sloping EMAs pointing downward indicate a weakening momentum, with prices closing below short-term averages [7]. - The MACD is confirming the weakness in momentum, providing deeper insights into the current market shifts [10].

Core Insights - Two stocks in the consumer discretionary sector are signaling potential warnings for momentum-focused investors as of November 25, 2025 [1] Company Performance - Ross Stores Inc reported better-than-expected third-quarter financial results and raised its fourth-quarter GAAP EPS guidance, with CEO Jim Conroy noting strong sales and customer engagement [6] - Ross Stores' stock gained approximately 10% over the past five days, reaching a 52-week high of $177.32, with an RSI value of 80.5 and a closing price of $176.50 [6] - Citi Trends reported second-quarter sales of $190.75 million, an 8% year-over-year increase, exceeding analyst expectations, and noted a 9.2% rise in comparable store sales for the fourth consecutive quarter [6] - Citi Trends' stock increased around 25% over the past month, achieving a 52-week high of $45.63, with an RSI value of 77.3 and a closing price of $45.17 [6]

Core Insights - The stock market experienced a sell-off driven by concerns over an AI bubble, affecting various equities, including those not directly linked to the AI sector [3][7] - The concept of "oversold" stocks suggests a potential for price reversion, particularly for companies with strong fundamentals and competitive advantages [4] - Technical indicators like the Relative Strength Index (RSI) are useful for identifying potential stock turnarounds, with readings below 30 indicating oversold conditions [5] Company Analysis - Oracle Corporation is positioning itself as a significant player in the AI industry, leveraging its cloud infrastructure and enterprise software for AI applications [6] - Despite being primarily known for cloud software and databases, Oracle's recent price correction is viewed as excessive, suggesting potential for recovery [6] - Analysts' 12-month price targets for Oracle and Super Micro Computer indicate substantial upside potential, as both stocks are currently in oversold territory [5][7]

Core Viewpoint - CyberArk (CYBR) has experienced a significant downtrend, with a 14.8% decline over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround due to improved earnings expectations from analysts [1]. Group 1: Technical Analysis - The Relative Strength Index (RSI) is a key technical indicator used to identify oversold conditions, with a reading below 30 typically indicating that a stock is oversold [2]. - CYBR's current RSI reading is 26.56, indicating that the heavy selling pressure may be exhausting, which could lead to a price rebound as the stock seeks to return to its previous equilibrium [5]. Group 2: Fundamental Analysis - There is strong consensus among sell-side analysts regarding an increase in earnings estimates for CYBR, with the consensus EPS estimate rising by 732.7% over the last 30 days, suggesting potential price appreciation in the near term [7]. - CYBR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further indicating a potential turnaround [8].

Core Viewpoint - Pacasmayo (CPAC) has experienced a significant downtrend, with a 13.1% decline over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround due to improved earnings expectations from analysts [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is a key technical indicator used to identify oversold conditions, with a reading below 30 indicating that a stock may be oversold [2]. - CPAC's current RSI reading is 27.11, indicating that the heavy selling pressure may be exhausting, and a price reversal could occur soon [5]. Group 2: Fundamental Indicators - Analysts have raised their earnings estimates for CPAC by 14.5% over the last 30 days, which typically correlates with price appreciation in the near term [7]. - CPAC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the potential for a turnaround [8].